Let us suppose that you were right about the FDA in China and that their standards become so high as to be equal to those of the US FDA. How much would it cost to get the approvals in the US and how much to get them done in China?
Also, if the results were acceptable to get an approval in China and their standards were as high as for the FDA over here, then the same results would produce the same approval, only that now, it would only be paper work; the work was done at a fraction of the cost in China.
The timing is important, but as long as the test works - AND ABBOTT PRESENTED RESULTS SHOWING THAT THEY DO - then the wait is worthwhile. Risky? Yes, but high risk entails high rewards. If the company makes it (and they made it before, with a technology that was not ready, without the serum tests and without licensees) then those buying at current prices will be handsomely rewarded.
I know you think the company will not make it, etc. I read your words to that effect FIVE MONTHS ago. What if it succeeds? What a waste of your time that would represent. Just think about it; the number of hours you invest on a company in which you have no shares and which on top and contrary to your best wishes refuses to disappear.
Some day you will look back on all this wasted time you could have used for so many other wonderful and positive things and you will shake your head in disbelief.
Until that happens, let us discuss my arguments above rather than jumping to something else, unless of course, you wish to concede the point.
AI
